IHIna Huppertz

Ina Huppertz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ina Huppertz has a total of 95 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Versatile and sensitive detection of mono- and poly(ADP-ribosyl)ation reveals XRCC1-dependent remodelling of PARP1 signalling

    by Helen Dauben, Mihaela Mihaljević, Andreas Kolvenbach, Maria Dilia Palumbieri, Chrysi Kapsali, Ina Huppertz, Ivan Matić

    ADP-ribosylation has long been recognised as a key regulator of essential signalling pathways, including the DNA damage response. However, only recent and ongoing technological advances are beginning to make it possible to investigate its distinct forms with molecular precision. Here, we design a ‘mono-ADP-ribosylation blocking’ strategy to develop sensitive, modular antibodies with high specificity for poly(ADP-ribosyl)ation. During peptide antigen generation, we identify a distinctive mass spectrometric signature that enables accurate mapping of poly(ADP-ribosyl)ation sites and helps prevent site mislocalization. Moreover, we affinity-mature mono-ADP-ribosylation and histone H3 site-specific antibodies. These tools reveal that, upon DNA damage, XRCC1 deficiency dramatically elevates the mono-ADP-ribosylation wave of PARP1 signalling, in addition to increasing poly(ADP-ribosyl)ation. This PARP1 hyperactivation leads to an increase in an unconventional form of ubiquitylation, recently shown to directly target mono-ADP-ribose in the DNA damage response and other signalling pathways. Consequently, XRCC1 loss enhances the recruitment of RNF114, the reader of this composite modification, to DNA lesions. These findings establish mono-ADP-ribosylation – and its ester-linked ubiquitylation – as key modifications induced by XRCC1 deficiency during DNA damage, revealed using tools we developed for precise and sensitive ADP-ribosylation detection.


  • Open Access

    Metabolic Crossroads: AMDHD2 Couples the Hexosamine Biosynthetic Pathway to Acetyl-CoA Homeostasis in Pluripotent Stem Cells

    by Virginia Kroef, Lea Hund, Yasmin Barenco Abbas, Norito Tamura, Jenny Fröhlich, Ann-Kathrin Huber, Syed Musa Ali, Lena Wischhof, Hannah Scheiblich, Patrick Giavalisco, et al.

    Pluripotent stem cells (SCs) rely on metabolic rewiring to regulate self-renewal and differentiation. The hexosamine biosynthetic pathway (HBP) integrates multiple metabolic inputs to produce uridine diphosphate-N-acetylglucosamine (UDP-GlcNAc), a central substrate for protein and lipid glycoconjugates. While UDP-GlcNAc levels influence pluripotency, the broader metabolic roles of the HBP in stem cell maintenance and differentiation remain largely unexplored. Using proteomic and metabolomic analyses, we uncovered extensive enzymatic remodelling of the HBP during early mouse embryonic stem cell (mESC) differentiation, including a significant decrease in N-acetylglucosamine-6-phosphate (GlcNAc6P) levels, despite stable UDP-GlcNAc levels. Isotope labelling experiments revealed that pluripotent stem cells maintain UDP-GlcNAc biosynthesis through a combination of glucose-driven de novo synthesis and the N-Acetylglucosamine (GlcNAc) salvage pathway, both of which are downregulated during differentiation. Functionally, we identified GlcNAc6P—a point of convergence of the de novo synthesis and the salvage pathways—as a pivotal metabolite of stem cell fate. Preventing GlcNAc6P’s deacetylation by deleting or depleting AMDHD2 impaired mESC differentiation. Mechanistically, we demonstrated that GlcNAc6P catabolism is essential for sustaining cytosolic acetate and in turn acetyl-CoA levels, which are critical for lipid synthesis and histone modifications required for pluripotency exit. These findings establish AMDHD2 as a key supplier of cellular acetate and reveal an essential metabolic link between HBP activity and acetyl-CoA homeostasis. By expanding the role of the HBP beyond UDP-GlcNAc production, this study reveals an unrecognised metabolic vulnerability that can be exploited to manipulate stem cell identity.

  • Top Cited Papers
    Open Access

    Riboregulation of Enolase 1 activity controls glycolysis and embryonic stem cell differentiation

    by Ina Huppertz, Joel I. Perez-Perri, Panagiotis Mantas, Thileepan Sekaran, Thomas Schwarzl, Francesco Russo, Dunja Ferring-Appel, Zuzana Koskova, Lyudmila Dimitrova-Paternoga, Eleni Kafkia, et al.


  • Open Access

    Vault RNA1–1 riboregulates the autophagic function of p62 by binding to lysine 7 and arginine 21, both of which are critical for p62 oligomerization

    by Magdalena Büscher, Rastislav Horos, Ina Huppertz, Kevin Haubrich, Nikolay Dobrev, Florence Baudin, Janosch Hennig, Matthias W. Hentze

    Cellular processes can be regulated at multiple levels, including transcriptional, post-transcriptional, and post-translational mechanisms. We have recently shown that the small, noncoding vault RNA1–1 negatively riboregulates p62 oligomerization in selective autophagy through direct interaction with the autophagic receptor. This function is highly specific for this Pol III transcript, but the determinants of this specificity and a mechanistic explanation of how vault RNA1–1 inhibits p62 oligomerization are lacking. Here, we combine biochemical and functional experiments to answer these questions. We show that the PB1 domain and adjacent linker region of p62 (aa 1–122) are necessary and sufficient for specific vault RNA1–1 binding, and we identify lysine 7 and arginine 21 as key hinges for p62 riboregulation. Chemical structure probing of vault RNA1–1 further reveals a central flexible loop within vault RNA1–1 that is required for the specific interaction with p62. Overall, our data provide molecular insight into how a small RNA riboregulates protein–protein interactions critical to the activation of specific autophagy.


  • Open Access

    The RNA-binding protein landscapes differ between mammalian organs and cultured cells

    by Joel I. Perez-Perri, Dunja Ferring-Appel, Ina Huppertz, Thomas Schwarzl, Frank Stein, Mandy Rettel, Bruno Galy, Matthias W. Hentze

    Summary: System-wide approaches have unveiled an unexpected breadth of the RNA-bound proteomes of cultured cells. Corresponding information regarding RNA-binding proteins (RBPs) of mammalian organs is still missing, largely due to technical challenges. Here, we describe ex vivo eRIC (enhanced RNA interactome capture) to characterize the poly(A)RNA-bound proteomes of three different mouse organs. The resulting organ atlases encompass more than 1300 RBPs active in brain, kidney or liver. Nearly a quarter (291) of these had formerly not been identified in cultured cells, with more than 100 being metabolic enzymes. Remarkably, RBP activity differs between organs independent of RBP abundance, suggesting organ-specific levels of control. Similarly, we identify systematic differences in RNA binding between animal organs and cultured cells. The pervasive RNA binding of enzymes of intermediary metabolism in organs points to tightly knit connections between gene expression and metabolism, and displays a particular enrichment for enzymes that use nucleotide cofactors. We describe a generically applicable refinement of the eRIC technology and provide an instructive resource of RBPs active in intact mammalian organs, including the brain.


  • Top Cited Papers
    Open Access

    TDP-43 condensation properties specify its RNA-binding and regulatory repertoire

    by Martina Hallegger, Anob M. Chakrabarti, Flora C.Y. Lee, Bo Lim Lee, Aram G. Amalietti, Hana M. Odeh, Katie E. Copley, Jack D. Rubien, Bede Portz, Klara Kuret, et al.


  • Open Access

    RNA regulates Glycolysis and Embryonic Stem Cell Differentiation via Enolase 1

    by Ina Huppertz, Joel I. Perez-Perri, Panagiotis Mantas, Thileepan Sekaran, Thomas Schwarzl, Lyudmila Dimitrova-Paternoga, Janosch Hennig, Pierre A. Neveu, Matthias W. Hentze

    Cells must coordinate their metabolism and fate trajectories ( 1, 2 ), but the underlying mechanisms are only beginning to be discovered. To understand why the glycolytic enzyme enolase 1 (ENO1) binds RNA ( 3–6 ), we studied this phenomenon in vitro, in human cells, and during mouse embryonic stem cell differentiation. We find specific cellular RNA ligands that inhibit ENO1’s enzymatic activity in vitro. Increasing the concentration of these ligands in cultured cells inhibits glycolysis. We demonstrate that pluripotent stem cells expressing an ENO1 mutant that is hyper-inhibited by RNA are severely impaired in their glycolytic capacity and in endodermal differentiation, whereas cells with an RNA binding-deficient ENO1 mutant display disproportionately high endodermal marker expression. Our findings uncover ENO1 riboregulation as a novel form of metabolic control. They also describe an unprecedented mechanism involved in the regulation of stem cell differentiation. One Sentence Summary: RNA directly regulates enzyme activity to control metabolism and stem cell fate


  • Open Access

    The RNA-Binding Protein YBX3 Controls Amino Acid Levels by Regulating SLC mRNA Abundance

    by Amy Cooke, Thomas Schwarzl, Ina Huppertz, Gertjan Kramer, Panagiotis Mantas, Anne-Marie Alleaume, Wolfgang Huber, Jeroen Krijgsveld, Matthias W. Hentze


  • Open Access

    ‘Read–through marking’ reveals differential nucleotide composition of read-through and truncated cDNAs in iCLIP

    by Ina Huppertz, Nejc Haberman, Jernej Ule

    We established a modified iCLIP protocol, called ‘read-through marking’, which facilitates the detection of cDNAs that have not been truncated upon encountering the RNA–peptide complex during reverse transcription (read-through cDNAs). A large proportion of these cDNAs would be undesirable in an iCLIP library, as it could affect the resolution of the method. To this end, we added an oligonucleotide to the 5’-end of RNA fragments—a 5’-marker—to mark the read-through cDNAs. By applying this modified iCLIP protocol to PTBP1 and eIF4A3, we found that the start sites of read-through cDNAs are enriched in adenosines, while the remaining cDNAs have a markedly different sequence content at their starts, preferentially containing thymidines. This finding in turn indicates that most of the reads in our iCLIP libraries are a product of truncation with valuable information regarding the proteins’ RNA-binding sites. Thus, cDNA start sites confidently identify a protein’s RNA-crosslink sites and we can account for the impact of read-through cDNAs by commonly adding a 5’-marker.


  • Open Access

    Erratum to: Insights into the design and interpretation of iCLIP experiments

    by Nejc Haberman, Ina Huppertz, Jan Attig, Julian König, Zhen Wang, Christian Hauer, Matthias W. Hentze, Andreas E. Kulozik, Hervé Le Hir, Tomaž Curk, et al.